Insider Cluster (2 insiders) ·Filed Aug 12, 2026

BLCO

Bausch & Lomb Corp
NEUTRAL
Impact 2/10
Horizonweeks Processed1mo ago
Insider cluster: 2 insiders, $988K total
Actionable Insight • Neutral

The insider sales are too small relative to market cap to carry informational value. Monitor the next 10-Q for any guidance changes or operational shifts, but this cluster alone does not warrant a trading response.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
BLCO ▲ +1.59% at T+20d
NEUTRAL call ✓ call won +1.59% · α vs SPY +3.34% · entry $16.98 → $17.25
Next anchor: T+60d in 5w
Latest observation: T+34 +3.47% FF3 residual α
Entry anchored
Aug 12, 2026
via day open
T+1d
+0.41%
call +0.41% · α +0.61%
$17.05
settled 7w ago
T+5d
+1.30%
call +1.30% · α +3.26%
$17.20
settled 6w ago
T+20d
+1.59%
call +1.59% · α +3.34%
$17.25
settled 22d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

Two insiders at Bausch & Lomb sold a combined $988K in open-market sales over a 5-day window, including the SVP/Controller and a director. The sales follow a board reshuffle that increased parent-company control and Q2 results showing 9% revenue growth. The total value is 0.016% of the $6.0B market cap, well below the 0.1% materiality threshold, making this a routine cluster with no informational signal.

Key Financial Metrics

Direction
selling
Total Value
$988.0K
Insiders
2

Key Facts

  • SVP/Controller Frederick Munsch sold 52,900 shares for $888K on 2026-08-10
  • Director Andrew von Eschenbach sold 18,559 shares total for $307K on 2026-08-06 and 2026-08-07
  • Total cluster value of $988K represents 0.016% of BLCO's $6.0B market cap
  • Sales occurred after Q2 revenue of $1.394B (+9% YoY) and reaffirmed guidance
  • Board reshuffle on 2026-08-06 replaced 4 independent directors with Bausch Health appointees

Financial Impact

Total insider sales of $988K, negligible relative to $6.0B market cap

Risk Factors

  • Insider sales could be misinterpreted as bearish by retail traders
  • Increased parent-company control may reduce board independence and minority-shareholder protections

Market Snapshot

Exchange
NYSE
Sector
Ophthalmic Goods
Analyst Consensus
56% bullish (18 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-BLCO-1786576012424
16 reports for BLCO
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+20▲ +6.48%Jul 29, 2026
Filters
Rows
Reports for BLCO — sortable, filterable
TypeNow
Aug 14, 2026
7w ago
3 / CLUSTER
NEUTRAL ★ 2/10
$17.00 $17.23▲ +1.35%▲ +3.33%$17.11 (+0.65%)
Aug 14, 2026
7w ago
3
NEUTRAL ★ 2/10
$17.00 $17.23▲ +1.35%▲ +3.33%$17.11 (+0.65%)
Aug 14, 2026
7w ago
3
NEUTRAL ★ 2/10
$17.00 $17.23▲ +1.35%▲ +3.33%$17.11 (+0.65%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$16.98 $17.25▲ +1.59%▲ +3.34%$17.11 (+0.77%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$16.98 $17.25▲ +1.59%▲ +3.34%$17.11 (+0.77%)
Aug 7, 2026
8w ago
144
NEUTRAL ★ 2/10
$16.83 $17.73▲ +5.35%▲ +6.26%$17.11 (+1.66%)
Aug 6, 2026
8w ago
144
NEUTRAL ★ 2/10
$16.35 $18.14▲ +10.95%▲ +10.35%$17.11 (+4.65%)
Aug 6, 2026
8w ago
8-K
MIXED ★ 5/10
$16.35 $18.14▲ +10.95%▲ +10.35%$17.11 (+4.65%)
Jul 29, 2026
9w ago
8-K
BULLISH ★ 6/10
$16.20 $17.25▲ +6.48%▲ +1.46%$17.11 (+5.62%)
Feb 27, 2026
31w ago
Insider Cluster
BULLISH ★ 7/10
$18.30 $15.37▼ −16.01%▼ −8.45%$17.11 (−6.50%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (38h 39m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 12, 2026